Cargando…
Prospects for RNAi Therapy of COVID-19
COVID-19 caused by the SARS-CoV-2 virus is a fast emerging disease with deadly consequences. The pulmonary system and lungs in particular are most prone to damage caused by the SARS-CoV-2 infection, which leaves a destructive footprint in the lung tissue, making it incapable of conducting its respir...
Autores principales: | Uludağ, Hasan, Parent, Kylie, Aliabadi, Hamidreza Montazeri, Haddadi, Azita |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7409875/ https://www.ncbi.nlm.nih.gov/pubmed/32850752 http://dx.doi.org/10.3389/fbioe.2020.00916 |
Ejemplares similares
-
Editorial: Current approaches to CRISPR/Cas9 delivery
por: Uludağ, Hasan, et al.
Publicado: (2022) -
Targeting Cell Cycle Proteins in Breast Cancer Cells with siRNA by Using Lipid-Substituted Polyethylenimines
por: Parmar, Manoj B., et al.
Publicado: (2015) -
Potential of siRNA in COVID-19 therapy: Emphasis on in silico design and nanoparticles based delivery
por: Fopase, Rushikesh, et al.
Publicado: (2023) -
Editorial: Enabling Biomaterials for New Biomedical Technologies and Clinical Therapies
por: Uludag, Hasan, et al.
Publicado: (2020) -
At the Intersection of Biomaterials and Gene Therapy: Progress in Non-viral Delivery of Nucleic Acids
por: Uludag, Hasan, et al.
Publicado: (2019)